Tag | Content |
---|
EnhancerAtlas ID | HS104-39681 |
Organism | Homo sapiens |
Tissue/cell | HUVEC |
Coordinate | chr3:15846670-15848460 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr3:15847615-15847633 | TGAAAGAAGGAAGGTATG | + | 6.07 | FOXF2 | MA0030.1 | chr3:15847308-15847322 | AATGTTTACCTTTA | - | 6.27 | MEF2C | MA0497.1 | chr3:15847527-15847542 | AGCTATTTTTAAATT | - | 6.06 | Nr2f6(var.2) | MA0728.1 | chr3:15848247-15848262 | TGAACTCCTGACCTC | - | 6.22 | RFX1 | MA0509.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | + | 6.05 | RFX1 | MA0509.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | - | 6.05 | RFX2 | MA0600.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | + | 6.11 | RFX2 | MA0600.2 | chr3:15847291-15847307 | AGTTGCTATGGTTACA | - | 6.14 |
|
| Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
SE_02838 | chr3:15847081-15848103 | Astrocytes | SE_12861 | chr3:15845772-15848342 | CD34_Primary_RO01480 | SE_13323 | chr3:15844928-15849098 | CD34_Primary_RO01536 | SE_14051 | chr3:15845292-15848580 | CD34_Primary_RO01549 | SE_38632 | chr3:15846337-15848597 | HUVEC | SE_44498 | chr3:15846605-15848104 | NHDF-Ad | SE_45074 | chr3:15846056-15848171 | NHLF | SE_45816 | chr3:15845860-15849011 | Osteoblasts | SE_52111 | chr3:15846983-15847606 | Skeletal_Muscle_Myoblast | SE_56307 | chr3:15846429-15847880 | u87 | SE_63925 | chr3:15846969-15847606 | HSMM |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr3 | 15847006 | 15847761 | chr3 | 15847096 | 15847637 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I015803 | chr3 | 15845146 | 15848878 |
|
Enhancer Sequence | AAGAATATAA GTAAAAAATT CAACAGGCCA AACTAACACA GGTTAGTTTT CTAGAATACA 60 CCTAATATGC CAAAACTAAG GAACAAAGGG AGAAAAACTA CTCTGTTAGC AAGTATGTAG 120 TACTGCATTT AAGTAATGTC TTTAAAAGTT AGGTTATTTT CTTCATAATT TTGATTACCT 180 TGAGAAGCAG TTTGAAATTA AGGAAAAGGA CTCATCATTT TAGAGGTCTT TTTTTTAAAG 240 TTGTGATACT TTTTAAAATA TCCTAGTCAA TCTGATTAGT AAAATTTTTA GCTAAGATAT 300 GTGATGAGTA GTATCTCTGA CATATGACTT ATGTTCTATC AGGCCAAGGA TAAACACATT 360 CTCTGAAATC TACATTATTA TTTGCAAAGT TAATTATTGT TCAGCAACTG TATCAAAGAC 420 AATTTAGCCC TCATATTAAA ATCAGTTGAG TGCAAAATTT TTATTTTAAA CAGGCTGAAT 480 TTTGCCCTTC TTAAAAAAAG ATTGAGGAAA GATTATGTGC AATTCATTCT GGTTTTTACA 540 ATGTGGTGAT GCCAGAGTAA ATGTAGTATG AAGTTAATGC ACTTTAAAAG CTGAAGGGAG 600 AAAATTTTCA GTTTTAAAAT AAGTTGCTAT GGTTACAAAA TGTTTACCTT TATAAGCAAT 660 AATTATGTGA GATGTCCAAG GAATTCCCGA AAGTACAGTA AGATCAGTAT CTGAAGTGTA 720 CATTCGTTAT TTCACAAACA AACTGAACCC AACTGCATAC ATCACTTCCG TTTCAAAGTG 780 GCTATCGTTT GGGAAATACT AAAAAAAAAA TGATTCATGT CTTTCTGAAC CATATTGGAG 840 ACAAAAATAC TGACCATAGC TATTTTTAAA TTCAAGTAAT GACTCAGAGA GTTTTAGTTC 900 CTTTTATCAA AGAGTGCTGT AATTTTACAT AGCACCTTCT ATTGTTGAAA GAAGGAAGGT 960 ATGTTTGTAA TGTGTCTCAG GTGTGGAGTT TCTTTTATAC ATAAATTTTC ACGCCTTCGA 1020 TAAACTTTTA AAAAGCCATG CTTGTAACAA TGTTAATTCA GAGTAAAACG ATGTCAACTC 1080 CTTTAGCTGT AGACAATTTT GAACTTCTTA AATGGGAAGA AGAGGCCCCT ATAAGAATTG 1140 ATAATTAGCC CATTCCTAAC TAGGTTGTTA AATCCGCTAT CAGTTACTGT ATTGTAGAAA 1200 TTTTTTGTGT GTCTGTGTTT TACATTTAGA ACATTCAGTT TTGTAAGACT ACTTATAAAA 1260 CTTTCAACCC CATATAGCTG ATCTTAAAAT TAGACGCTCA TCATTACCTC TTAGAAGGCA 1320 GCTATGCTCA CCACTATACC AACACTGCTG CCATCATCAC ATCTTTTTTT TTTTTTGAGA 1380 CAGAGTCTCA CTCTGTCACC CAGGCTGGAG TGCAGTGGCA CAATCCCAGC TCACTGCAAC 1440 CTCCACCTCC TGGGTTCAAG TGATTCTCCT GCCTCAGCCT CCCGAGTAGC TGGGATTACA 1500 GGCGCATGCC ACCACGCCCA GCTAATTTTT GTATTTTTAG TAAAGACAGC GTTTTACCAT 1560 TTTGGCCAGG CTGCTCTTGA ACTCCTGACC TCAGGTGATT CGCCCACCTC GGACTCCCAA 1620 AGTGTTAGGA TTACAGGCAT GAGCCACCAT GTCCGGCCCA TCATGACATC TTAATGGGCC 1680 TTCCACCAGT GTCTACTTTC TATGTAATAG AATATTAAAC ACATTTGTTA ATATTAGGCC 1740 TATCCTAAGC CAAAAATAAT TTATAAAATA AGATGTTACT CTCAACTGGC 1790
|